Thursday, April 2, 2026
ADVT 
Health

Study Finds If Diarrhea Serve A Purpose

Darpan News Desk IANS, 16 Jun, 2017 11:28 PM
    Despite thousands of years of pant-crapping history, there's a surprising amount we don't know about diarrhea. Does it actually help clear the bacteria causing a gastrointestinal infection, or is it merely a symptom of disease that should be prevented as much as possible?
     
    In a new study from Brigham and Women's Hospital, investigators explore the immune mechanism that drives diarrhea, concluding that it does play a critical role in pathogen clearance in the early stages of infection.
     
    The new study, published in Cell Host and Microbe, also uncovers a previously unrecognized role for interleukin-22, an immune system molecule, in the host's defense against infection.
     
    "The hypothesis that diarrhea clears intestinal pathogens has been debated for centuries," said corresponding author Jerrold Turner, MD, PhD, of the BWH Departments of Pathology and Medicine.
     
    "Its impact on the progression of intestinal infections remains poorly understood. We sought to define the role of diarrhea and to see if preventing it might actually delay pathogen clearance and prolong disease."
     
    To investigate, researchers used a mouse model infected with Citrobacter rodentium, the mouse equivalent of an E. coli infection. Using this model, they saw an increase in the permeability of the intestinal barrier within just two days of infection -- well before inflammation and epithelial damage.
     
    In particular, they uncovered a critical role for interleukin-22 that in turn influences another molecule called claudin-2, previously known to be involved in causing diarrhea.
     
    They found that diarrhea resulting from the signaling of these two molecules helped promote pathogen clearance and limited disease severity.
     
    Other investigators have proposed developing new therapeutics to inhibit claudin-2. However, Turner and colleagues explain that the activation of this pathway may be critical for combating an infection, particularly in the early stages of a disease.
     
    They conclude that diarrhea is critical to enteric pathogen clearance, and that IL-22 may play a key role in host defense.

    MORE Health ARTICLES

    Treatment of muscular dystrophy possible

    Treatment of muscular dystrophy possible
    In what could lead to the discovery of drugs to treat muscle weakening diseases such as muscular dystrophy, researchers have discovered...

    Treatment of muscular dystrophy possible

    E-nose can help customise asthma treatment

    E-nose can help customise asthma treatment
    Rather than a 'one size fits all' approach, an electronic nose can help health professionals tailor asthma treatment to suit individuals....

    E-nose can help customise asthma treatment

    Novel technique to help repair muscles

    Novel technique to help repair muscles
    In the hope of treating millions of people suffering from muscle diseases, US researchers have developed a novel technique to promote...

    Novel technique to help repair muscles

    New blood test may offer personalised ovarian cancer treatment

    New blood test may offer personalised ovarian cancer treatment
    Researchers have discovered that a combination of proteins is the key to ovarian cancer treatment, leading them to come up with a blood test that...

    New blood test may offer personalised ovarian cancer treatment

    Plant cells may help treat hemophilia

    Plant cells may help treat hemophilia
    Treating hemophilia, a rare bleeding disorder in which the blood does not clot normally, could be a lot cheaper and much safer as researchers...

    Plant cells may help treat hemophilia

    Safety data expected in Nov., Ebola vaccines may be used before end of 2014

    Safety data expected in Nov., Ebola vaccines may be used before end of 2014
    TORONTO - The World Health Organization says experimental Ebola vaccines may be ready to be used before the end of 2014.

    Safety data expected in Nov., Ebola vaccines may be used before end of 2014